Texas Biomed working to accelerate COVID-19 drug development July 20, 2022 Researchers at Texas Biomed have received approval to work with a weakened, non-harmful version of SARS-CoV-2 in biosafety level 2 (BSL-2) laboratories, which makes it safer, faster and easier to...
Texas Biomed tapped for national ‘Dream Team’ developing antivirals against COVID-19 and other threats July 16, 2022
Preclinical demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants March 18, 2022
Glowing viruses allow San Antonio researchers to track how COVID-19 spreads in real time November 04, 2021
Texas Biomed scientists use ‘reporter gene’ to track how coronavirus moves through the body October 13, 2021
New live vaccine protects against equine influenza: Keeping animals healthy also protects people April 30, 2018
